Syllable
PrivateLast Round
Series C
Apr 28, 2022
Total Funding Raised
$86M
Company Overview
Syllable operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Series C round in April 2022.
Syllable is a healthcare technology company that provides an AI-powered platform for automating patient-facing communications and call-center workflows for health systems and enterprises.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Patient Engagement, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syllable Comparables
Compare Syllable with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyro | 90% | |
| Assort Health | 89% | |
| Luma Health | 89% |
For institutional investors. Book with your work email.
Syllable Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 28, 2022 | ||||
| Series B | Jun 30, 2021 | ||||
| Series A | Sep 10, 2018 | ||||
| Seed | Mar 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Syllable Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series C, Series B, Series A |
| Greylock Partners | Seed |
| TCV | Series C |
| New Enterprise Associates | Seed |
| Khosla Ventures | Seed |
| Oak HC/FT | Series C, Series B |
| TCV | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Launched Responsive Dialogue for more natural conversations.
- Dec 2, 2025
Agentic AI platform now available for purchase and deployment.
For institutional investors. Book with your work email.
Syllable Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Syllable's valuation, stock price, and market status.
Is Syllable a public or private company?
Syllable is a private company.
What is the current stock price of Syllable?
Syllable is a private company, so its shares have no public market price. Caplight tracks Syllable's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Syllable worth (valuation)?
Valuation information for Syllable is not publicly available.
Can I buy Syllable stock?
Syllable shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Syllable's last funding round?
Syllable's most recent funding round was Series C on April 28, 2022.
Who are the main investors in Syllable?
Key investors in Syllable include TCV, Oak HC/FT, TCV.
Will Syllable IPO soon?
No public IPO plans have been announced for Syllable.
How can I track Syllable secondary market activity?
Caplight tracks bids, offers, and trades in Syllable's shares on secondary markets.